B&V Capital Advisors, Investment Bankers and IR Global Member, selected for Convergence Ventures Fund II

Published 21 May 2019 by B&V Capital Advisors

B&V Capital Advisors, LLC is pleased to announce that it has been selected as the exclusive placement agent for Convergence Ventures Fund II. Convergence is a Houston, Texas based fund raising institutional capital to be placed in a portfolio of Texas-based biotechnology, pharma, medical devices and AI for medical application companies. The primary investment interest will be on those entities focused on cancer related solutions and Cancer Prevention and Research Institute of Texas (CPRIT) grants from the state of Texas.

The long term goal is to build a sustainable, thriving biotechnology and life science industry in Texas and become the next wave of new business growth opportunities.

Discussions with domestic and international institutional quality investors interested in the rapidly growing life sciences sector are being pursued.

About B&V Capital Advisors, LLC

B&V Capital Advisors, LLC specializes in sell side, buy side and recapitalization advisory services for companies with earnings in excess of $1.5mm and estimated enterprise value exceeding $10mm. Current initiatives include representative engagements in the power, petrochemical, construction, healthcare, food and beverage and consumer goods sectors.

Investment Banking Services and Securities offered through Independent Investment Bankers Corp. a broker-dealer, Member FINRA/SIPC

B&V Capital Advisors, LLC is not affiliated with Independent Investment Bankers Corp.

To learn more about B&V Capital Advisors, LLC, please visit our website.